Suffolk s tourist industry will also be given a much needed boost as hotels and other types of accommodation can open to guests, previously only self-catering accommodation with no shared facilities could open.
Step 3 will mean that 30 people will be able to attend weddings, receptions, funerals, and commemorative events including wakes.
The four steps set out in the national roadmap will apply to all regions of England at the same time.
And following the move to Step 3, it is likely that more settings will be allowed to open unless a specific exemption exists.
Drinkers raise their pints at The Woolpack
in Ipswich Picture: Sonya Duncan
The New Wolsey Theatre, Ipswich, basking in the summer sunshine Photo: Lucy Taylor
Pubs, restaurants, theatres, hotels and indoor attractions across Suffolk and north Essex are preparing to fully reopen as the Government continues on its roadmap out of lockdown.
Following the successful reopening of hairdressers, pub gardens, and non essential shops, we are expecting Step 3 of the easing of Covid-19 lockdown rules to happen from Monday, May 17, 2021.
The Unruly Pig, in Bromeswell near Woodbridge, has been named among the UK s top 10 gastropubs Picture: Tim Bowden
- Credit: Tim Bowden
The main change is that indoor hospitality will be allowed, meaning pubs like the award-winning Unruly Pig in Bromeswell, will be able to offer indoor dining again.
GSRGT 2020: SWOG S1823 - MicroRNA 371 for Outcome Prediction in Patients with Germ Cell Tumors
(Urotoday.com) The newly formed Global Society of Rare Genitourinary Tumors (GSRGT) held its inaugural meeting, focusing on penile and testicular cancer. The session held Saturday, December 12
th focused on testis cancer. In this session, the organizers convened a “Clinical Trials Corner” in which Dr. Craig Nichols presented an update on the SWOG S1823 study, a prospective observational cohort study assessing microRNA 371 for outcome prediction in patients with germ cell tumors.
Dr. Nichols began by highlighting data from a pilot study of miR-371. In a 2x2 analysis assessing patients with germ cell tumors with or without clinically confirmed germ cell malignancy (GCM), these pilot data demonstrated promising test characteristics: sensitivity of 96% (95% confidence interval 85-99%), the specificity of 100% (95% CI 96-100%, the positive predictive value of 100% (95% CI 92-100%)